Skip to content

Recurrence in High-grade Lesions After Conization

Presence of Positive Resection Margins, Hypooestrogenism and Specimen Volume May Influence Risk of Disease Recurrence in Patients With High-grade Cervical Intra-epithelial Neoplasia Undergoing Large Loop Excision of the Transformation Zone

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02540421
Enrollment
103
Registered
2015-09-04
Start date
2001-01-31
Completion date
2007-12-31
Last updated
2015-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Intraepithelial Neoplasia

Keywords

cervical intraepithelial neoplasia, human papillomavirus, conization

Brief summary

Objectives: To identify factors associated with disease recurrence in patients with high-grade cervical intra-epithelial neoplasia (CIN) undergoing large loop excision of the transformation zone (LLETZ). Study Design: A case-control study that included 103 patients. Patients were included in the study if they had a history of surgery for conization by LLETZ for the histopathological diagnosis of cervical intraepithelial neoplasia grades II and III (CIN II and CIN III). Follow-up exams were conducted every six months with Pap smear collection and colposcopic examination with biopsy, when necessary, for a minimum period of twelve months. Cure was defined as a normal follow-up examination within 24 months. During follow-up, relapse occurred when cytology and/or biopsy results showed that CIN had returned after 12 months, at which time a new cervical conization by LLETZ was performed.

Interventions

None listed

Sponsors

Faculdade de Medicina do ABC
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1\. history of surgery for conization

Exclusion criteria

1. under 18 years of age, 2. immunosuppressed, 3. Patient with a histopathological diagnosis of low-grade intraepithelial neoplasia 4. Patient with invasion, or surgical margins obtained by LLETZ that were unable to be evaluated.

Design outcomes

Primary

MeasureTime frameDescription
Recurrence rates after conization12 monthsNumber of patients who are regarded as recurrence based on the following criteria: \- relapse occurred when cytology and/or biopsy showed that CIN had returned after 12 months

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026